Avalyn Pharma Inc. (AVLN)
NASDAQ: AVLN · Real-Time Price · USD
31.45
+2.14 (7.30%)
At close: Jun 18, 2026, 4:00 PM EDT
32.00
+0.55 (1.75%)
After-hours: Jun 18, 2026, 6:01 PM EDT
Avalyn Pharma Market Cap
Avalyn Pharma has a market cap or net worth of $1.31 billion as of June 18, 2026.
Market Cap
1.31B
Enterprise Value
1.18B
1-Year Change
n/a
Ranking
Category
Stock Price
$31.45
Market Cap Chart
Since the IPO on April 30, 2026, Avalyn Pharma's market cap has increased from $752.62M to $1.31B, an increase of 74.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.31B | 7.30% |
| Jun 17, 2026 | 1.23B | 4.42% |
| Jun 16, 2026 | 1.17B | -2.37% |
| Jun 15, 2026 | 1.20B | -4.42% |
| Jun 12, 2026 | 1.26B | 7.16% |
| Jun 11, 2026 | 1.17B | -1.61% |
| Jun 10, 2026 | 1.19B | -0.49% |
| Jun 9, 2026 | 1.20B | 2.17% |
| Jun 8, 2026 | 1.17B | 3.70% |
| Jun 5, 2026 | 1.13B | 0.26% |
| Jun 4, 2026 | 1.13B | 2.23% |
| Jun 3, 2026 | 1.10B | 2.64% |
| Jun 2, 2026 | 1.08B | -3.53% |
| Jun 1, 2026 | 1.11B | -7.37% |
| May 29, 2026 | 1.20B | 1.37% |
| May 28, 2026 | 1.19B | 5.85% |
| May 27, 2026 | 1.12B | 0.45% |
| May 26, 2026 | 1.12B | -7.42% |
| May 22, 2026 | 1.21B | 1.51% |
| May 21, 2026 | 1.19B | 1.36% |
| May 20, 2026 | 1.17B | -0.28% |
| May 19, 2026 | 1.18B | 5.56% |
| May 18, 2026 | 1.11B | -10.76% |
| May 15, 2026 | 1.25B | -2.55% |
| May 14, 2026 | 1.28B | -0.68% |
| May 13, 2026 | 1.29B | 3.11% |
| May 12, 2026 | 1.25B | 1.12% |
| May 11, 2026 | 1.24B | 8.20% |
| May 8, 2026 | 1.14B | 1.49% |
| May 7, 2026 | 1.13B | -2.81% |
| May 6, 2026 | 1.16B | 1.02% |
| May 5, 2026 | 1.15B | -5.64% |
| May 4, 2026 | 1.22B | -2.58% |
| May 1, 2026 | 1.25B | 65.78% |
| Apr 30, 2026 | 752.62M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MoonLake Immunotherapeutics | 1.41B |
| Savara | 1.39B |
| Inhibrx Biosciences | 1.37B |
| Maravai LifeSciences Holdings | 1.34B |
| Immatics | 1.34B |
| Aktis Oncology | 1.33B |
| MapLight Therapeutics | 1.31B |
| Damora Therapeutics | 1.31B |